Trial Details

COMPLETED
Basic Information
Clinical ID c4289
Identifier NCT00740103
Trial Title Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Semapimod
Participant Information
Sponsor Ferring Pharmaceuticals
City San Francisco
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2002-12
Primary Completion Date 2004-07
Completion Date 2004-09